bioRxiv Science⌕ Search

Biology subjects

Bishop, S. L.

Publications and source records attributed to Bishop, S. L..

3 recordsLinked to original sources

An agentic AI environment to support biomedical research in collaborative academic environments

Agentic artificial intelligence (AAI) is increasingly used by biomedical scientists, where it has substantially lowered the difficulty of integrating computational, statistical and data-science approaches into day-to-day research activities, assisting with project design, analysis and manuscript preparation. Significant barriers remain, however, which are unlikely to be removed solely by releasing more capable AI models. Meaningful use still demands a technical fluency that many biomedical researchers lack: a PI and their lab members must learn how to use the AAI system, establish standard operating procedures (SOPs) for managing, sharing and curating data, and enforce rules that address data privacy and security. Existing commercial AAI systems, which were designed primarily for software engineering purposes, need to be significantly re-purposed for biomedical-related data science. We present Murmurent, shared software that sits beneath the agentic AI and provides the skills, procedures and protections to address the concerns above, removing the need for a lab to develop them independently. This includes (1) infrastructure to support projects and so-called choreographies} involving multiple group members; (2) a set of specialized agents each dedicated to typical biomedical data science tasks including software and statistical development, data visualization, literature search, equity, diversity, inclusion, and decolonization (EDID) review, and others; (3) a tiered memory which can retain important research decisions, intermediate, derived outputs and sensitive data, and which can exploit this information to automatically build better contexts in AAI sessions; (4) traceability records which are used by the AAI session to better plan and execute data analyses and software builds by, for example, helping to avoid repeating decisions that lead to dead-ends; (5) enforcement of SOPs for data maintenance and data governance across all lab members; and (6) multi-user capacity to allow groups to interact and collaborate. We use the system to identify putative inhibitors of Peptidyl-prolyl cis-trans Isomerase NIMA-interacting 1 (Pin1), a protein with a shallow catalytic site making it difficult to target. We describe the construction of several approaches to identify Pin1 inhibitors and the results they yield. Murmurent is open source.

bioinformatics↗

SCALiR: a web application for automating absolute quantification of mass spectrometry-based metabolomics data

Metabolomics is an important approach for studying complex biological systems. Quantitative liquid chromatography-mass spectrometry (LC-MS)-based metabolomics is becoming a mainstream strategy but presents several technical challenges that limit its widespread use. Computing metabolite concentrations using standard curves generated from standard mixtures of known concentrations is a labor-intensive process which is often performed manually. Currently, there are few options for open-source software tools that can automatically calculate metabolite concentrations. Herein, we introduce SCALiR (Standard Curve Application for determining Linear Ranges), a new web-based software tool specifically built for this task, which allows users to automatically transform LC-MS signal data into absolute quantitative data (https://www.lewisresearchgroup.org/software). The algorithm used in SCALiR automatically finds the equation of the line of best fit for each standard curve and uses this equation to calculate compound concentrations from their LC-MS signal. Using a standard mix containing 77 metabolites, we found excellent correlation between the concentrations calculated by SCALiR and the expected concentrations of each compound (R2 = 0.99) and that SCALiR reproducibly calculated concentrations of mid-range standards across ten analytical batches (average coefficient of variation 0.091). SCALiR offers users several advantages, including that it (1) is open-source and vendor agnostic; (2) requires only 10 seconds of analysis time to compute concentrations of >75 compounds; (3) facilitates automation of quantitative workflows; and (4) performs deterministic evaluation of compound quantification limits. SCALiR provides the metabolomics community with a simple and rapid tool that enables rigorous and reproducible quantitative metabolomics studies.

biochemistry↗

Method for quantifying the metabolic boundary fluxes of cell cultures in large cohorts by high resolution hydrophilic liquid chromatography mass spectrometry

Metabolomics is a mainstream approach for investigating the metabolic underpinnings of complex biological phenomena and is increasingly being applied to large scale studies involving hundreds or thousands of samples. Although metabolomics methods are robust in smaller scale studies, they can be challenging to apply in larger cohorts due to the inherent variability of liquid chromatography mass spectrometry (LC-MS). Much of this difficulty results from the time-dependent changes in the LC-MS system, which affects both the qualitative and quantitative performance of the instrument. Herein, we introduce an analytical strategy for addressing this problem in large-scale microbial studies. Our approach quantifies microbial boundary fluxes using two zwitterionic hydrophilic interaction liquid chromatography (ZIC-HILIC) columns that are plumbed to enable offline column equilibration. Using this strategy, we show that over 360 common metabolites can be resolved in 4.5 minutes per sample and that metabolites can be quantified with a median coefficient of variation of 0.127 across 1,100 technical replicates. We illustrate the utility of this strategy via an analysis of 960 strains of Staphylococcus aureus isolated from blood stream infections. These data capture the diversity of metabolic phenotypes observed in clinical isolates and provide an example of how large-scale investigations can leverage our novel analytical strategy.

biochemistry↗